Class information for:
Level 2: FIBRINOLYSIS//PLASMINOGEN ACTIVATOR INHIBITOR 1//PAI 1

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
1157 9477 35.8 68%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
111 3       THROMBOSIS RESEARCH//THROMBOSIS AND HAEMOSTASIS//HEMATOLOGY 71244
1157 2             FIBRINOLYSIS//PLASMINOGEN ACTIVATOR INHIBITOR 1//PAI 1 9477
961 1                   PLASMINOGEN ACTIVATOR INHIBITOR 1//PAI 1//FIBRINOLYSIS 2936
4791 1                   FIBRINOGEN//FACTOR VII//FIBRINOGEN ASSAYS 1725
11624 1                   JOHN COOK RENAL UNIT//PLATELET HYPERSENSITIVITY//5 4 CHLOROBENZYL 2 4 DIMETHYLBENZAMIL 966
14741 1                   THROMBOSIS RESEARCH//BETA THROMBOGLOBULIN//ACTIVE STRESSOR 753
15403 1                   POLYASPARTOYL L ARGININE//BEIJING S HYDRONE PEPTIDES//PLATELETS 715
16473 1                   RECEPTOR C K//BCL 2 AND CYCLIN D EXPRESSION//RECEPTOR C K INDUCTION 651
17825 1                   INTERNAL MED THER EUTCLIN MED//24 H PLATELET ACTIVITY//AB INITIO SCF DFT 580
18741 1                   ATHLETIC HORSE//B TG//FISIOL COMPARATA ESERCIZIO FIS 537
29367 1                   VESSEL WALL INJURY//PERITONEAL DISSEMINATED TUMOR MODEL//THROMBOEMBOLISM PATHOPHYSIOLOGY 187
30901 1                   DERMCIDIN ISOFORM 2//ACUTE ISCHEMIC HEART DISEASE//ANTITHROMBIC STRATEGIES 161
32103 1                   CLIN BIOCHEM IMMUNOHEMATOL//INTERDISCIPLINARY EXCELLENCE PROGRAM HLTH AGI//NATURAL ANTIPLATELET AGENTS 144
33591 1                   CARDIOSPERMUM HALICACABUM//CARDIOSPERMUM HALICACABUM L//BIOKINET INTER PROBLEM 122

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 FIBRINOLYSIS authKW 342170 7% 17% 635
2 PLASMINOGEN ACTIVATOR INHIBITOR 1 authKW 307904 3% 29% 325
3 PAI 1 authKW 240470 3% 27% 275
4 FIBRINOGEN authKW 226360 6% 13% 527
5 PLASMINOGEN ACTIVATOR INHIBITOR authKW 186225 2% 32% 182
6 THROMBOSIS RESEARCH journal 176717 8% 7% 750
7 THROMBOSIS AND HAEMOSTASIS journal 163966 8% 7% 713
8 FACTOR VII authKW 127031 1% 28% 139
9 HEMATOLOGY WoSSC 112935 33% 1% 3168
10 PERIPHERAL VASCULAR DISEASES WoSSC 107097 31% 1% 2970

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Hematology 112935 33% 1% 3168
2 Peripheral Vascular Diseases 107097 31% 1% 2970
3 Cardiac & Cardiovascular System 10371 14% 0% 1328
4 Endocrinology & Metabolism 3184 8% 0% 779
5 Medicine, Research & Experimental 2199 7% 0% 645
6 Medicine, General & Internal 1463 7% 0% 701
7 Pharmacology & Pharmacy 659 8% 0% 718
8 Medical Laboratory Technology 520 1% 0% 141
9 Biochemistry & Molecular Biology 416 10% 0% 989
10 Nutrition & Dietetics 296 2% 0% 201

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 PHARMACEUT BIOL PHYTOPHARMACOL 78048 1% 51% 48
2 CELLULAR PROT SCI 30045 0% 67% 14
3 CLIN CHEM BLOOD COAGULAT 25832 0% 47% 17
4 EPIDEMIOL MED CARE UNIT 23445 0% 30% 24
5 INTERDISCIPLINARY EXCELLENCE PROGRAM HLTH AGI 15760 0% 35% 14
6 ANGELA VALENTI THROMBOSIS PHARMACOL 14487 0% 75% 6
7 EPI 9936 14487 0% 75% 6
8 GAUBIUS 14168 1% 8% 57
9 CLIN BIOCHEM IMMUNOHEMATOL 13649 0% 28% 15
10 UNIT MOL VASC MED 11594 0% 16% 22

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 FIBRINOLYSIS 215375 2% 32% 208
2 THROMBOSIS RESEARCH 176717 8% 7% 750
3 THROMBOSIS AND HAEMOSTASIS 163966 8% 7% 713
4 FIBRINOLYSIS & PROTEOLYSIS 64040 1% 28% 70
5 BLOOD COAGULATION & FIBRINOLYSIS 31881 2% 6% 181
6 HAEMOSTASIS 27473 1% 8% 103
7 ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 21125 2% 3% 223
8 ARTERIOSCLEROSIS AND THROMBOSIS 12394 1% 7% 57
9 PLATELETS 11389 1% 5% 78
10 ATHEROSCLEROSIS 9223 2% 2% 177

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 FIBRINOLYSIS 342170 7% 17% 635 Search FIBRINOLYSIS Search FIBRINOLYSIS
2 PLASMINOGEN ACTIVATOR INHIBITOR 1 307904 3% 29% 325 Search PLASMINOGEN+ACTIVATOR+INHIBITOR+1 Search PLASMINOGEN+ACTIVATOR+INHIBITOR+1
3 PAI 1 240470 3% 27% 275 Search PAI+1 Search PAI+1
4 FIBRINOGEN 226360 6% 13% 527 Search FIBRINOGEN Search FIBRINOGEN
5 PLASMINOGEN ACTIVATOR INHIBITOR 186225 2% 32% 182 Search PLASMINOGEN+ACTIVATOR+INHIBITOR Search PLASMINOGEN+ACTIVATOR+INHIBITOR
6 FACTOR VII 127031 1% 28% 139 Search FACTOR+VII Search FACTOR+VII
7 PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1 106570 1% 39% 84 Search PLASMINOGEN+ACTIVATOR+INHIBITOR+TYPE+1 Search PLASMINOGEN+ACTIVATOR+INHIBITOR+TYPE+1
8 PLATELETS 76747 6% 4% 540 Search PLATELETS Search PLATELETS
9 TISSUE TYPE PLASMINOGEN ACTIVATOR 62647 1% 17% 114 Search TISSUE+TYPE+PLASMINOGEN+ACTIVATOR Search TISSUE+TYPE+PLASMINOGEN+ACTIVATOR
10 4G 5G POLYMORPHISM 61738 0% 91% 21 Search 4G+5G+POLYMORPHISM Search 4G+5G+POLYMORPHISM

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 VAN DE CRAEN, B , DECLERCK, PJ , GILS, A , (2012) THE BIOCHEMISTRY, PHYSIOLOGY AND PATHOLOGICAL ROLES OF PAI-1 AND THE REQUIREMENTS FOR PAI-1 INHIBITION IN VIVO.THROMBOSIS RESEARCH. VOL. 130. ISSUE 4. P. 576-585 130 82% 31
2 GILS, A , DECLERCK, PJ , (2004) PLASMINOGEN ACTIVATOR INHIBITOR-1.CURRENT MEDICINAL CHEMISTRY. VOL. 11. ISSUE 17. P. 2323-2334 150 78% 36
3 GILS, A , DECLERCK, PJ , (2004) THE STRUCTURAL BASIS FOR THE PATHOPHYSIOLOGICAL RELEVANCE OF PAL-L IN CARDIOVASCULAR DISEASES AND THE DEVELOPMENT OF POTENTIAL PAL-L INHIBITORS.THROMBOSIS AND HAEMOSTASIS. VOL. 91. ISSUE 3. P. 425-437 137 78% 66
4 HUBER, K , (2001) PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 (PART ONE): BASIC MECHANISMS, REGULATION, AND ROLE FOR THROMBOEMBOLIC DISEASE.JOURNAL OF THROMBOSIS AND THROMBOLYSIS. VOL. 11. ISSUE 3. P. 183 -193 140 84% 52
5 DECLERCK, PJ , GILS, A , (2013) THREE DECADES OF RESEARCH ON PLASMINOGEN ACTIVATOR INHIBITOR-1: A MULTIFACETED SERPIN.SEMINARS IN THROMBOSIS AND HEMOSTASIS. VOL. 39. ISSUE 4. P. 356-364 105 70% 33
6 POSTHUMA, JJ , VAN DER MEIJDEN, PEJ , TEN CATE, H , SPRONK, HMH , (2015) SHORT- AND LONG-TERM EXERCISE INDUCED ALTERATIONS IN HAEMOSTASIS: A REVIEW OF THE LITERATURE.BLOOD REVIEWS. VOL. 29. ISSUE 3. P. 171 -178 77 90% 7
7 HOEKSTRA, T , GELEIJNSE, JM , SCHOUTEN, EG , KLUFT, C , (2004) PLASMINOGEN ACTIVATOR INHIBITOR-TYPE I: ITS PLASMA DETERMINANTS AND RELATION WITH CARDIOVASCULAR RISK.THROMBOSIS AND HAEMOSTASIS. VOL. 91. ISSUE 5. P. 861-872 123 72% 85
8 CESARI, M , PAHOR, M , INCALZI, RA , (2010) PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1): A KEY FACTOR LINKING FIBRINOLYSIS AND AGE-RELATED SUBCLINICAL AND CLINICAL CONDITIONS.CARDIOVASCULAR THERAPEUTICS. VOL. 28. ISSUE 5. P. E72 -E91 135 51% 72
9 EL-SAYED, MS , ALI, ZE , AHMADIZAD, S , (2004) EXERCISE AND TRAINING EFFECTS ON BLOOD HAEMOSTASIS IN HEALTH AND DISEASE - AN UPDATE.SPORTS MEDICINE. VOL. 34. ISSUE 3. P. 181-200 98 90% 56
10 JUHANVAGUE, I , ALESSI, MC , (1996) FIBRINOLYSIS AND RISK OF CORONARY ARTERY DISEASE.FIBRINOLYSIS. VOL. 10. ISSUE 3. P. 127-136 127 84% 37

Classes with closest relation at Level 2


Rank Class id link
1 2572 UROKINASE RECEPTOR//UPAR//UPA
2 2447 DYSFIBRINOGENEMIA//AFIBRINOGENEMIA//FIBRINOGEN
3 1214 FACTOR XIII//TRANSGLUTAMINASE//TRANSGLUTAMINASE 2
4 697 MEAN PLATELET VOLUME//PLATELETS//HEMATOLOGY
5 637 TISSUE FACTOR//THROMBOMODULIN//PROTEIN C
6 2062 VON WILLEBRAND DISEASE//VON WILLEBRAND FACTOR//ENDOCAN
7 3458 MASPIN//TAFI//THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR
8 1784 CLINICAL HEMORHEOLOGY//CLINICAL HEMORHEOLOGY AND MICROCIRCULATION//HEMORHEOLOGY
9 1311 PROSTAGLANDIN D 2//CRTH2//MOL BEHAV BIOL
10 966 CLOPIDOGREL//PRASUGREL//TICAGRELOR

Go to start page